Ep 48: Anna Sjöblom & ReAct. Population ab use & the gut microbiome. Host-specific plasmid evolution.
Spring is back in Sweden, and so are we in your ears! This month of May we bring you an interview with Anna Sjöblom, director of ReAct Europe, a branch of an international organization working to promote and deliver action on antibiotic resistance. We learn about Anna’s background, the path that led her to ReAct, and many of the activities that ReAct has done and have currently ongoing.
In the news section, we cover the latest expert policy brief published by ReAct, a recent article looking into how antibiotic use at a country level can affect the gut microbiome, and a study revealing that the evolutionary pathways of plasmids in a clinical setting might be more difficult to predict than previously thought. Thanks for tuning in!
You can follow us and subscribe to our podcast to get new episodes directly in your preferred device and platform:
Relevant links:
- Anna Sjöblom's twitter profile.
- ReAct - Action on Antibiotic Resistance's website.
- ReAct's toolbox. Get information, inspiration and tools to take action on antibiotic resistance.
Further Reading:
- Expert Policy Brief: 5 take aways and public not-for-profit solutions in early stages antibiotics R&D. Lastest brief published by ReAct and presented in the news section.
- Population-level impacts of antibiotic usage on the human gut microbiome. First article covered in the news.
- Population's antibiotic use can affect individual health, study shows. Popular news published in the New Atlas magazine on the first article.
- Host-specific plasmid evolution explains the variable spread of clinical antibiotic-resistance plasmids. Second article covered in the news.
If you have any comments and suggestions you can email us here, or tweet to us (@UAC_UU) using the hashtag #theAMRStudio.